Targeted Medical Pharma Profit Margin 2014-2015 | TRGM
Current and historical gross margin, operating margin and net profit margin for Targeted Medical Pharma (TRGM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Targeted Medical Pharma net profit margin as of December 31, 2015 is 0%.
| Targeted Medical Pharma Annual Profit Margins |
| Targeted Medical Pharma Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Targeted Medical Pharma, Inc. is a biotechnology company. It develops amino acid based medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The Company also develops a line of dietary supplements designed to support health and wellness. It is also developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I. Targeted Medical Pharma, Inc. is based in Los Angeles, California.
|
